The Effect of Augmented Reality Based Training on Preeclampsia Case

NCT ID: NCT06730048

Last Updated: 2024-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

84 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-20

Study Completion Date

2025-08-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

However, no study has been found in the care of preeclampsia, which is highly effective on maternal and fetal health. Therefore, this study was planned to determine the effect of augmented reality-based training on the diagnosis and intervention planning skills of nursing students.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Although pregnancy is a physiological process in women's lives, many women lose their lives due to the lack of timely and appropriate treatment of the complications it brings with it. According to the World Health Organization 2024 report, approximately 800 women die every day due to preventable causes related to pregnancy and childbirth. Preeclampsia, which is among the hypertensive diseases of pregnancy, is a complication of pregnancy and ranks among the top three causes of maternal mortality worldwide. Preeclampsia is defined as hypertension that develops after the 20th week of pregnancy and is accompanied by proteinuria/thrombocytopenia, renal failure, liver dysfunction, and cerebral/visual symptoms.

Considering the risks of preeclampsia complications, taking precautions before the onset of complications and treating complications with appropriate methods are extremely important in reducing the mortality rates of both pregnant and fetus. In order to maintain safe patient care and the health of individuals, nurses should know what kind of nursing care should be applied in the antenatal period to diagnose, evaluate and prevent complications of preeclampsia. In the literature, it is recommended that nursing care for preeclampsia patients should include the diagnoses of infection risk, disruption in sleep pattern, acute pain, constipation, impaired physical movement, lack of self-care, and fatigue. Nursing care should include individualized, holistic, systematic, high quality, feasible, applicable, sustainable care methods including technological methods, models and theories for all pregnant women with more than 2 of the risks of preeclampsia by ACOG.

Technological methods, which have been frequently used in the health system in recent years, are used because they are cheap, usable, accelerate the decision-making process, and reduce workload. Virtual reality (VR) applications are technological applications that create a reality environment with the help of scenarios and facilitate learning complex cases and diseases by increasing students' knowledge and skills. In addition, this method allows students to develop critical thinking skills, participate in clinical decision-making processes and receive feedback. In the literature, VR application has been used in triage patients and nursing care of pediatric patients. However, no study has been found in the care of preeclampsia, which is highly effective on maternal and fetal health. Therefore, this study was planned to determine the effect of augmented reality-based training on the diagnosis and intervention planning skills of nursing students.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preeclampsia Nursing Care Pregnancy Augmented Reality

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

preeclampsia nursing care pregnancy augmented reality

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

two-group study, experimental and control group
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
experimental group will use augmented reality sension and outcome assessments will be performend by a investigator who was blinded to group allocation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

experimental group

An appointment will be made to meet with the students in the experimental group in a suitable classroom of the school. After the pre-test data, the students in the experimental group will be shown the preeclampsia case with virtual glasses for about 5-10 minutes. Then the post-test will be applied. A scenario including preeclampsia case and nursing care practices will be created in the virtual reality environment, and 10 experts will be consulted about the scenario before the students are shown it. This application will not have any side effects.

Group Type EXPERIMENTAL

Experimental Group

Intervention Type OTHER

An appointment will be made to meet with the students in the experimental group in a suitable classroom of the school. After the pre-test data, the students in the experimental group will be shown the preeclampsia case with virtual glasses for about 5-10 minutes. Then the post-test will be applied. A scenario including preeclampsia case and nursing care practices will be created in the virtual reality environment, and 10 experts will be consulted about the scenario before the students are shown it. This application will not have any side effects.

control group

After the pre-test data, the preeclampsia case will be explained to the students in the control group with the classical lecture method in the Women's Health and Diseases Nursing course and the post-test will be applied.

Group Type OTHER

Control group (placebo)

Intervention Type OTHER

After the pre-test data, the preeclampsia case will be explained to the students in the control group with the classical lecture method in the Women's Health and Diseases Nursing course and the post-test will be applied.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Experimental Group

An appointment will be made to meet with the students in the experimental group in a suitable classroom of the school. After the pre-test data, the students in the experimental group will be shown the preeclampsia case with virtual glasses for about 5-10 minutes. Then the post-test will be applied. A scenario including preeclampsia case and nursing care practices will be created in the virtual reality environment, and 10 experts will be consulted about the scenario before the students are shown it. This application will not have any side effects.

Intervention Type OTHER

Control group (placebo)

After the pre-test data, the preeclampsia case will be explained to the students in the control group with the classical lecture method in the Women's Health and Diseases Nursing course and the post-test will be applied.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Continuing the course of Women's Health and Diseases Nursing,

* Volunteering to participate in the research,
* No physical or psychological health problems preventing the completion of the research forms.

Exclusion Criteria

* \- Not watching the whole case given with virtual glasses,
* Failure to attend class during the week of the preeclampsia lecture in the course syllabus.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Inonu University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Simge Ozturk

Ph.D Student

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Inonu University

Malatya, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

simge öztürk, Ph.D

Role: CONTACT

Phone: 05398751788

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

simge öztürk, Ph.D

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Inonu3

Identifier Type: -

Identifier Source: org_study_id